Abstract: A survey of 104 sexually active young females tested on on cervico-vaginal swabs showed that 26 of the females (25%) had vulvovaginal candidiasis with a species distribution of Candida isolates accounting for 13 (50%) with C. albicans, 6 (23%) with C. glabrata, 1 (4%) with C. krusei, and 6 (23%) with C. tropicalis. Of the 26 (25 %) subjects that were positive for VVC, 8 (7.8 %) were symptomatic and 18 (18.8 %) were asymptomatic. However, distribution among different age groups revealed an increase in the 23-27 age group. The comparative analysis of sensitivity of the given fungi to the number of antimycotic preparations used revealed the following: in fluconazole, 2 (7.8%) isolates were sensitive, 5 (19.2%) were susceptible and dose dependent, and 19 (73%) were resistant. For voriconazole, 4 (18.4%) isolates were sensitive, 6 (23.1%) were susceptible and dose dependent, and 16 (61.5%) were resistant. For nystatin, 5 (19.2%) isolates were sensitive, 10 (38.5%) were susceptible and dose dependent, and 11 (42.3%) were resistant. It appears that Candida isolates have a variable resistance response, but 19 (73%) had maximum resistance of the isolated fungi of the genus Candida to fluconazole. Therefore, further studies on the evaluation of combination therapy should be considered for a better outcome in treatment of vulvovaginal candidiasis.
Introduction
Vulvovaginal candidiasis (VVC) is a common fungal infection that affects healthy women of all ages. At least 75% of women will develop one or more infections once during their lifetime, with 5 to 8% of those individuals developing recurrent infections. In Nigeria, an estimate of 28 million adult Nigerian women, representing about 75% of the female population there, are believed to have suffered itchy vaginal candidiasis at least once in their lifetime [1] . In addition, in Ondo South West Nigeria, a study revealed that 83% of female patients attending Ondo State Hospital suffer from vaginal candidiasis [2] . Vaginal candidiasis has been treated with topical azole antifungal medications in single or short term doses [3] . It has been well documented that most candida isolates demonstrate both intrinsically low susceptibility to the azoles, as well as the ability to develop resistance [4] .
Moreover, a recent increase in the trailing or low-level resistance phenotype to the azoles has been observed in the C. glabrata and tropicalis isolates from various parts of the world [5] . Surveillance programs performed over the past few decades have demonstrated that although azole resistance is rare in Candida albicans isolates (<1%), it is becoming very common among isolates of non-albican species (up to 15%) [6] . The rise in VVC infections, and more specifically in non-albicans species, could be due to several factors ranging from an increase in over-the-counter antifungal use to an increase in high-risk patient populations (i.e., sexually active young females). C. glabrata is the primary nonalbicans species emerging in VVC, accounting for up to 14% of infections in immune-competent women [7] .
In the Osogbo metropolis, there is a paucity of information on the prevalence and distribution of candida species, particularly those due to the non-albican species. Therefore, the study of antifungal resistance profiles in these isolates is important, since the information could provide physicians with information concerning the proper treatment for their patients, and the baseline data could possibly address some of these issues of recurrent VVC in the study location. This study was therefore aimed at documenting the prevalence of vaginal candidiasis, and also to determine the susceptibility of each Candida to various antifungal drugs among undergraduate students of Ladoke Akintola University of Technology, Osogbo campus.
Material and Methods

Sample Processing and Antifungal Disc Susceptibility Test
A total of 104 vaginal swabs were collected at the health center from supposedly healthy volunteer female students from Ladoke Akintola University, Osogbo campus. The cervico-vaginal swabs were tested for Candida isolates by streaking the swab sticks onto Sabouraud Dextrose agar that was supplemented with 6µg gentamicin, and unto 5% blood agar using the rolling method. These plates were incubated at 37 o C for 24 hours. All the plates that showed no growth were further incubated for at least 72 hours before they were discarded. Isolates that gave a positive Gram staining reaction and characteristic budding morphology were further identified using sugar fermentation test according to standard microbiological methods [8] .
Disc diffusion testing was performed according to conventional standard microbiological techniques [8] by using Fluconazole (25µg), Voriconazole (100units), and Nystatin (1µg), which were all obtained from oxoid (UK). Inocula were prepared by suspending colonies from overnight Sabouraud dextrose agar plates in sterile saline to the turbidity of a 0.5 Mcfarland standard, which was spread over a Muller Hinton agar (Oxoid, Bakingstoke, United Kingdom) that was supplemented with 0.2 % glucose and 0.5 µg/ml methylene blue dye using a swap sick. The discs were dispensed unto the surface of inoculated agar plates and incubated overnight at 37ºC. For fluconazole, (25µg) the following were used for interpretation: ≥17mm is susceptible, 16- 
Statistical analysis
The significance of the results was determined by using the Chi-square method and was obtained manually. The differences were considered to be statistically significant when the p value obtained was less than 0.05 (p < 0.05), and not significant when the p value was greater than 0.05 (p < 0.05).
Results
Of the 104 subjects that were recruited into the study, 26 (25%) were positive for VVC, out of which 8 (7.8%) were symptomatic and 18 (18.8%) were asymptomatic. The subjects were divided into three age group categories, which were 18-22, 23-27, and 28 years and above. Their corresponding prevalences were 5 (15.6 %), 18 (35.3%), and 3 (14.3%), as shown in Figure 1 . Out of the 26 positive isolates, C. albicans had the highest occurrence with 13 (50%) isolates, followed by C. glabrata and C. tropicalis, both of which had 6 (23%) each. C. krusei was the least isolated 1 (4%). This is shown in Table 1 . The Candida species isolated were matched with each predisposing factor, as shown in Table 2 .
There were 16 (15.4 %) previously exposed subjects, 5 (4.8 %) subjects with recurrent cases, 25 (24%) subjects who regularly washed their vagina with 
Isolates
Number Percentage soap, 24 (23%) subjects whom regularly wore tight fitting pants,15 (14.4%) subjects who regularly used bath additives like hygienic foam bath, izal, dettol etc., 9 (4.8%) subjects on antibiotics, 1 (0.96%) subject who often used vagina deodorant, 1 (0.96%) subject who took oral contraceptives, and 5 (4.8 %) subjects who were on corticosteroid. Sensitivity testing, as shown in Table 3 , revealed that for fluconazole, 2 (7.8%) isolates were sensitive, 5 (19.2%) were susceptible to becoming dose dependent, and 19 (73%) were resistant. For voriconazole, 4 (18.4%) isolates were sensitive, 6 (23.1%) were susceptible to becoming dose dependent, and 16 (61.5%) were resistant. For nystatin, 5 (19.2%) isolates were sensitive, 10 (38.5%) were susceptible to becoming dose dependent, and 11 (42.3%) were resistant. C. krusei was noted and identified to have a resistance to all antifungal.
Discussion
Between the ages of puberty and young adulthood, many factors may predispose a young female to vaginal discomfort, of which VVC continues to be considered the most common cause of vaginitis among young women [10] . In most parts of developing countries, Nigeria in particular, VVC is normally not seen as a serious disease condition because most of the time, it stops on the slightest application of an antifungal agent. It only becomes a concern when it is experienced after several attempts are made to treat it without success. Among the undergraduate population studied, the distribution of Candida species between the different age groups was compared. The data showed a significant (P≤0.05) increase in the prevalence of the albicans species. The data also showed that the age bracket that was most afflicted with VVC was from ages 23 to 27 years. Therefore, there was an association between age and the prevalence of VVC, as shown in Figure 1 . Two studies from Nigeria, one in Jos, reported that the highest prevalence of Candida isolates was between ages 22-26 [11] , and between ages 21-25, rather than other age groups in Ife [12] . The vulnerability of these age groups could be explained with respect to increased sexual activity, drug abuse, and use of contraceptives. [5] .
This study also showed a positive association (X² = 10.135, P < 0.05) with behavioral practices, such as regular washing of the vagina with soap and wearing tight fitting pants, as possible factors contributing to the occurrence of VVC. This trend of study was corroborated by previous studies [14] . Prevalence of VVC among subjects in this study gave 26/104(25%), which was comparable with earlier studies in India [15] and in Brazil [16] with rates ranging from 20.8 to 23%, while a higher prevalence of 65% was reported in apparently healthy female college students [17] . More over, In Edo State Nigeria, a prevalence of 49% was documented [10] , while another study among female students of the University of Jos showed a prevalence of 59.5% [11] . Their study also reported a higher prevalence of non-albicans vaginitis [18] . The high prevalence of non-albicans Candida in their study was comparable with previous workers. The increase in non-albicans Candida in their study were possibly due to wide spread resistance, inappropriate use of antifungal medication, long term maintenance treatments, and repeated treatments of VVC episode [19] . In contrast, a higher frequency of Candida albican was obtained in the present study; this distribution of Candida species is consistent with previously published surveys with previous reports by some authors [20] .
Differences in the prevalence of VVC, as compared with other studies, could be attributed to differences in geographical location and identification techniques [19] . In this study, antifungal susceptibility showed varying degrees of resistance. For fluconazole, 2 (7.8%) isolates were sensitive, 5 (19.2%) were susceptible to being dose dependent, and 19 (73%) were resistant. Resistance with respect to the species showed C. albicans to have a high resistance of 84.62% to fluconazole. Previous work by some authors reported a resistance range of 17.7% -27% [4] . However no resistance to fluconazole was reported in a study done in US, among women with vaginal candidiasis [10] . Voriconazole and nystatin resistance on isolates of C. albicans were observed to have a resistance of 69.23% and 61.54% respectively, which contradicted previous findings that documented the resistance frequency to be 1.3% [21] . Among the non-albicans Candida subjects, fluconazole resistance was 66.2% for C. tropicalis, 50% for C. glabrata, and 100% for C. krusei. Nystatin resistance was 16.67% for C. glabrata, 33.3% for C. tropicalis, and susceptible to being dose dependent for C. kruesi. Also, this study showed that nystatin was more susceptible than the azole antifungal agent. In contrast to recommendations of sexually transmitted disease treatment guidelines of VVC, azoles are regarded as being more effective than nystatin [3] . It could be suggested that resistance to the azole antifungal may be attributed to cross resistance as this is common among the azoles on Candida isolates and uncommon among the polyenes [22] . Alternative agents like boric acid and flucytosine have been reported to be more effective [4] and should therefore be used in treatment of non-albicans candida.
Conclusively, VVC, which is largely treated empirically, presents both a diagnostic and therapeutic challenge. Inappropriate management may result in the progression to complicated vaginitis, resulting due to inadequate treatment. Enhancement of antifungal resistance may develop, leading to co-infections with microbes which could lead to infertility [23] . Understanding the genetic factors responsible for resistance in the distribution of Candida isolates in our environment warrant further studies.
